RELEASE: Norgine Expands Scientific Engagement with Veeva Link Key People

New system improves real-time customer insights, launch planning and engagement in new therapies.

RELEASE: Norgine Expands Scientific Engagement with Veeva Link Key People

New system improves real-time customer insights, launch planning and engagement in new therapies

BARCELONA, Spain, July 27, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Norgine B.V. (Norgine), a leading European specialty pharmaceutical company, is using real-time customer intelligence from Veeva Link Key People to drive effective launch planning and expert engagement as it expands into new therapeutic areas. Leveraging Link Key People in Europe, Australia and New Zealand, Norgine's medical teams gain valuable market insights on top scientific, digital and community leaders for increased visibility of scientific engagement across all regions.

"At Norgine, we are dedicated to bringing life-changing medicines to patients with unmet needs faster," said Dr. Jonathan Jones, Norgine's vice president of medical affairs. "Early engagement with key experts creates a deep understanding of treatments to reach patients most effectively. Veeva Link Key People helps us identify emerging and existing thought leaders and their scientific communities to make every interaction relevant." for the needs of the patients from the beginning".

With Link Key People, Norgine's medical teams have a complete picture of the scientific activities of experts across all channels. Insights from their research, clinical trials, and conference attendance help Norgine lead effective field planning and mapping key opinion leaders for more personalized field engagements.

"We are committed to helping Norgine broaden and deepen its relationships within the scientific community as it brings new treatments to patients," said Kilian Weiss, general manager of Veeva Link. "With Veeva Link Key People, Norgine can quickly recruit the right experts and stay current on evolving trends to drive significant pre- and post-launch planning and engagement."

Veeva Link's connected data applications deliver real-time intelligence in multiple areas, including key people, key accounts, scientific awareness, and medical insights. It is part of the Veeva Commercial Cloud, a family of software, data, and services to promote business excellence in the life sciences.

Additional InformationFor more information on Veeva Link Key People, visit: Connect with Veeva on LinkedIn:

About Veeva Systems Veeva is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, from the world's largest biopharmaceutical companies to emerging biotech companies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit

Veeva's Forward-Looking Statements This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we are under no obligation to update such statements. There are numerous risks that could adversely affect our results, including the risks and uncertainties disclosed in our Form 10-Q filing for the period ended April 30, 2023, which you can find here (pages 37-38 for a summary). risks that may affect our business), and in our subsequent filings with the SEC, which you can access at


Jeremy WhittakerVeeva Systems

Logo -

View original content: